Seeking Alpha

LRUSF
  Lorus Therapeutics, Inc. - OTCPK - Current

8/22/2014, 12:32 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
LRUSF vs. ETF Alternatives
Company Description
Lorus is a clinical stage cancer drug development company with a strong commitment to discovering and developing innovative molecular targeted therapies addressing major unmet medical needs.
Sector: Healthcare
Country: Canada